OMRX (OMRX) Stock Price & Analysis
OMRX (OMRX) rose 0.00% to USD 0 as of June 10, 2026 at 12:53 UTC, according to Nexqual real-time market data.
OMRX last closed at USD 0; the session ranged USD 0–0 on volume of 800 shares. Market capitalization is $74,457, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 12:53 UTC.
Key Statistics (as of June 10, 2026 at 12:53 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 800 shares |
| Market Cap | $74,457 |
| Exchange | PNK |
Technical Analysis (OMRX)
Nexqual's technical model rates OMRX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 12:53 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (OMRX)
Wall Street analysts rate OMRX "None", per Nexqual as of June 10, 2026 at 12:53 UTC.
| Consensus Rating | None |
|---|
Earnings (OMRX)
Source: Nexqual, June 10, 2026 at 12:53 UTC.
Financials & Fundamentals (OMRX)
| Total Revenue | $1.46M |
|---|---|
| Revenue Growth (YoY) | -82.10% |
| Gross Margin | +40.57% |
| Operating Margin | -184.58% |
| Profit Margin | -65.85% |
| Current Ratio | 0.13 |
| Total Cash | $2,332 |
| Total Debt | $2.61M |
| Free Cash Flow | $-148,512 |
Source: Nexqual, June 10, 2026 at 12:53 UTC.
Financial Health Score (OMRX)
Nexqual rates OMRX's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 12:53 UTC.
| Growth | Critical — Revenue -82% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $2K cash vs $3M debt |
| Cash Flow | Weak — FCF negative: -$149K, burning cash |
| Efficiency | Mixed — No data |
Ownership (OMRX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 0 |
Source: Nexqual, June 10, 2026 at 12:53 UTC.
Leadership (OMRX)
OMRX is led by Reynald G. Bonmati M.Sc. Ch.E. (age 77), Founder, Chief Executive Officer, President, Treasurer and Chairman of the Board, per Nexqual as of June 10, 2026 at 12:53 UTC.
| Founder, Chief Executive Officer, President, Treasurer and Chairman of the Board | Reynald G. Bonmati M.Sc. Ch.E. (age 77) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIMU | Non-Invasive Monitoring Systems | USD 0.06 | ▼ 14.29% |
| OPTL | OPTIMUM INTERACTIVE USA LTD | USD 0 | ▲ 0% |
| ADLI | AMERICAN MEDICAL TECHNOLOGIES | USD 0 | ▲ 0% |
| POSC | Positron Corp. | USD 1.86 | ▲ 0% |
| NWCI | NEWCARDIO INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:53 UTC. This page is informational and not investment advice.